Sergey Brezgin

1.1k total citations
44 papers, 759 citations indexed

About

Sergey Brezgin is a scholar working on Molecular Biology, Epidemiology and Hepatology. According to data from OpenAlex, Sergey Brezgin has authored 44 papers receiving a total of 759 indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Molecular Biology, 17 papers in Epidemiology and 7 papers in Hepatology. Recurrent topics in Sergey Brezgin's work include CRISPR and Genetic Engineering (17 papers), Hepatitis B Virus Studies (13 papers) and RNA Interference and Gene Delivery (11 papers). Sergey Brezgin is often cited by papers focused on CRISPR and Genetic Engineering (17 papers), Hepatitis B Virus Studies (13 papers) and RNA Interference and Gene Delivery (11 papers). Sergey Brezgin collaborates with scholars based in Russia, United Kingdom and Tajikistan. Sergey Brezgin's co-authors include Dmitry Kostyushev, Vladimir Chulanov, Anastasiya Kostyusheva, Dieter Glebe, E. V Volchkova, Irina Goptar, Yu.Yu. Babin, Alexander N. Lukashev, Andrey A. Zamyatnin and Alessandro Parodi and has published in prestigious journals such as SHILAP Revista de lepidopterología, Scientific Reports and International Journal of Molecular Sciences.

In The Last Decade

Sergey Brezgin

40 papers receiving 751 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sergey Brezgin Russia 15 573 188 91 89 81 44 759
Anastasiya Kostyusheva Russia 15 575 1.0× 178 0.9× 84 0.9× 91 1.0× 84 1.0× 43 759
Dmitry Kostyushev Russia 16 632 1.1× 203 1.1× 101 1.1× 104 1.2× 130 1.6× 64 943
Tristan Scott United States 13 484 0.8× 101 0.5× 29 0.3× 73 0.8× 27 0.3× 24 668
Sandesh Subramanya United States 14 474 0.8× 119 0.6× 29 0.3× 90 1.0× 36 0.4× 19 819
Tingting Pan China 9 522 0.9× 163 0.9× 166 1.8× 168 1.9× 19 0.2× 11 768
Amy C. H. Lee United States 11 699 1.2× 221 1.2× 84 0.9× 229 2.6× 38 0.5× 18 1.1k
Elena Herrera-Carrillo Netherlands 18 754 1.3× 84 0.4× 50 0.5× 141 1.6× 12 0.1× 48 936
Pei‐Yu Chu Taiwan 16 274 0.5× 225 1.2× 41 0.5× 90 1.0× 22 0.3× 38 729
Yongzhe Zhu China 17 243 0.4× 222 1.2× 185 2.0× 27 0.3× 24 0.3× 29 770
Elena Bekerman United States 9 226 0.4× 132 0.7× 42 0.5× 31 0.3× 38 0.5× 9 763

Countries citing papers authored by Sergey Brezgin

Since Specialization
Citations

This map shows the geographic impact of Sergey Brezgin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sergey Brezgin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sergey Brezgin more than expected).

Fields of papers citing papers by Sergey Brezgin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sergey Brezgin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sergey Brezgin. The network helps show where Sergey Brezgin may publish in the future.

Co-authorship network of co-authors of Sergey Brezgin

This figure shows the co-authorship network connecting the top 25 collaborators of Sergey Brezgin. A scholar is included among the top collaborators of Sergey Brezgin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sergey Brezgin. Sergey Brezgin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Brezgin, Sergey, Anastasiya Kostyusheva, Vladimir Chulanov, et al.. (2025). Overcoming Antibiotic Resistance and Treating Bacterial Infections with Biological Nanoparticles. International Journal of Molecular Sciences. 26(24). 11780–11780.
2.
Brezgin, Sergey, Irina Goptar, Vladimir Chulanov, et al.. (2025). The Role of m6A-RNA Methylation in the Development, Progression, and Treatment Response of Bladder Cancer. Biochemistry (Moscow). 90(6). 650–670. 1 indexed citations
3.
Brezgin, Sergey, Anastasiya Kostyusheva, Н.В. Пономарева, et al.. (2024). Basic Guide for Approaching Drug Delivery with Extracellular Vesicles. International Journal of Molecular Sciences. 25(19). 10401–10401. 12 indexed citations
4.
Kostyusheva, Anastasiya, Sergey Brezgin, Н.В. Пономарева, et al.. (2024). Clinical and Translational Landscape of Viral Gene Therapies. Cells. 13(22). 1916–1916. 5 indexed citations
5.
Brezgin, Sergey, Alexander N. Lukashev, Vadim S. Pokrovsky, et al.. (2024). m6A Methylation in Regulation of Antiviral Innate Immunity. Viruses. 16(4). 601–601. 7 indexed citations
6.
Brezgin, Sergey, Anastasiya Kostyusheva, Ekaterina Bayurova, et al.. (2023). Hydroxychloroquine Enhances Cytotoxic Properties of Extracellular Vesicles and Extracellular Vesicle–Mimetic Nanovesicles Loaded with Chemotherapeutics. Pharmaceutics. 15(2). 534–534. 9 indexed citations
7.
Kostyushev, Dmitry, Anastasiya Kostyusheva, Sergey Brezgin, et al.. (2023). Depleting hepatitis B virus relaxed circular DNA is necessary for resolution of infection by CRISPR-Cas9. Molecular Therapy — Nucleic Acids. 31. 482–493. 20 indexed citations
8.
Kostyushev, Dmitry, Anastasiya Kostyusheva, Sergey Brezgin, et al.. (2023). Proteolytic Resistance Determines Albumin Nanoparticle Drug Delivery Properties and Increases Cathepsin B, D, and G Expression. International Journal of Molecular Sciences. 24(12). 10245–10245. 10 indexed citations
9.
Brezgin, Sergey, Alessandro Parodi, Anastasiya Kostyusheva, et al.. (2023). Technological aspects of manufacturing and analytical control of biological nanoparticles. Biotechnology Advances. 64. 108122–108122. 32 indexed citations
10.
Kostyushev, Dmitry, et al.. (2022). Previous hepatitis B viral infection–an underestimated cause of pancreatic cancer. World Journal of Gastroenterology. 28(33). 4812–4822. 5 indexed citations
11.
Brezgin, Sergey, et al.. (2022). БЕЛОК НВХ ПОТЕНЦИРУЕТ РЕАКТИВАЦИЮ ВИРУСА ГЕПАТИТА В. Молекулярная биология. 56(5). 783–794. 1 indexed citations
12.
Kostyushev, Dmitry, et al.. (2021). May Previous Hepatitis B Virus Infection Be Involved in Etiology and Pathogenesis of Autoimmune Liver Diseases?. Advances in Therapy. 39(1). 430–440. 7 indexed citations
13.
Kostyushev, Dmitry, et al.. (2021). CRISPR/Cas and Hepatitis B Therapy: Technological Advances and Practical Barriers. Nucleic Acid Therapeutics. 32(1). 14–28. 4 indexed citations
14.
Kostyusheva, Anastasiya, Sergey Brezgin, Yu.Yu. Babin, et al.. (2021). CRISPR-Cas systems for diagnosing infectious diseases. Methods. 203. 431–446. 115 indexed citations
15.
16.
Kostyushev, Dmitry, et al.. (2019). Suppressing the NHEJ pathway by DNA-PKcs inhibitor NU7026 prevents degradation of HBV cccDNA cleaved by CRISPR/Cas9. Scientific Reports. 9(1). 1847–1847. 46 indexed citations
17.
Kostyushev, Dmitry, et al.. (2019). Orthologous CRISPR/Cas9 systems for specific and efficient degradation of covalently closed circular DNA of hepatitis B virus. Cellular and Molecular Life Sciences. 76(9). 1779–1794. 63 indexed citations
18.
Kostyushev, Dmitry, et al.. (2018). INCREASED FORMATION OF PHOSPHORYLATED H2AX FOCI IN NUCLEI OF CELLS INFECTED BY HEPATITIS B AND B+D VIRUSES. Problems of Virology. 63(4). 165–170. 2 indexed citations
19.
Kostyushev, Dmitry, Sergey Brezgin, Dieter Glebe, et al.. (2017). Overexpression of DNA-methyltransferases in persistency of cccDNA pool in chronic hepatitis B. Terapevticheskii arkhiv. 89(11). 21–26. 6 indexed citations
20.
Chulanov, Vladimir, et al.. (2017). Hepatitis C can be cured: will hepatitis B become next?. Terapevticheskii arkhiv. 89(11). 4–13. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Anastasiya Kostyusheva Breakdown of academic impact, for papers by Dmitry Kostyushev Breakdown of academic impact, for papers by Tristan Scott Breakdown of academic impact, for papers by Sandesh Subramanya Breakdown of academic impact, for papers by Tingting Pan Breakdown of academic impact, for papers by Amy C. H. Lee Breakdown of academic impact, for papers by Elena Herrera-Carrillo Breakdown of academic impact, for papers by Pei‐Yu Chu Breakdown of academic impact, for papers by Yongzhe Zhu Breakdown of academic impact, for papers by Elena Bekerman
Rankless by CCL
2026